Editors' note: Rare side effects of alemtuzumab remind us of the need for postmarketing surveillance

Muraro et al. highlighted recent reports of rare complications related to alemtuzumab. While adverse events associated with this highly effective multiple sclerosis therapy have been identified in clinical trials, the importance of postmarketing surveillance cannot be understated.

from Neurology recent issues https://ift.tt/2Fk1IYO